Enhanced Recovery Protocols for Gynecologic Cancer
Enhanced Recovery Protocols in Gynecologic Oncology
Recruiting
Observational Study
ERAS
Gynecologic Cancer
Perioperative Complication
Postoperative Pain
Quality of Life
Infections
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 25 – 85
- Sex
- Female
- Study type
- Observational
- Participants needed
- 600 (estimated)
- Sponsor
- National and Kapodistrian University of Athens · Other
Who this trial is looking for
This trial is looking for women with gynecological cancer to participate in a program aimed at improving recovery after surgery. Involvement includes following a structured plan to help with recovery and comparing results with others who may not fully meet the plan's requirements.
Are You a Good Fit for This Trial?
You may be able to join if
- I have been diagnosed with gynecological cancer
- I have an ECOG performance status less than 4
- I have an ASA score less than 4
You may not be able to join if
- I have metastatic cancer that is not gynecological
- I cannot follow the recovery protocol due to medical reasons
- I have severe debilitating health issues
- I have an ECOG status of 4
- I have an ASA score of 4 or 5
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Enhanced Recovery After Surgery (ERAS) are developed to provide a systematic structure for managing postsurgical patients.These protocols promote evidenced-based practices and implement a multidisciplinary effort to maintain normal physiology in the perioperative period and aid in earlier recovery. The present study aims to investigate the feasibility of and compliance to a structured ERAS protoco…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
patients with gynaecological cancer and an ECOG performance status \<4, ASA score \<4.
Exclusion Criteria:
patients with metastatic cancer of non-gynaecological origin patients that are not able to follow ERAS protocol due to medical reasons patients with severe debilitating c…
Contacts